Steven M. Grauer

United States Military Academy — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

15h-index1.1kcitations22works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Receptor Mechanisms and Signaling(9), Neurotransmitter Receptor Influence on Behavior(8), Neuroscience and Neuropharmacology Research(4), Neuropeptides and Animal Physiology(4), Nicotinic Acetylcholine Receptors Study(4)

Publications22 total

Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na<sub>v</sub>1.7 for the Treatment of Pain
Journal of Medicinal Chemistry·2021· 21 citedOpen Access
Antinociceptive effects of potent, selective and brain penetrant muscarinic M4 positive allosteric modulators in rodent pain models
Brain Research·2020· 2 cited
MitoPark mice, an animal model of Parkinson’s disease, show enhanced prepulse inhibition of acoustic startle and no loss of gating in response to the adenosine A2A antagonist SCH 412348
Psychopharmacology·2013· 14 cited
Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625
Psychopharmacology·2011· 20 cited
The Synthesis and Biological Evaluation of Quinolyl-piperazinyl Piperidines as Potent Serotonin 5-HT<sub>1A</sub>Antagonists
Journal of Medicinal Chemistry·2010· 15 citedOpen Access
Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes
Proceedings of the National Academy of Sciences·2010· 82 citedOpen Access
COMPOUND 1, A POTENT AND SELECTIVE DAO INHIBITOR, DEMONSTRATES EFFICACY IN SEVERAL PRECLINICAL ANIMAL MODELS OF SCHIZOPHRENIA
Schizophrenia Research·2010
WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: A Novel Dopamine D2 Receptor Partial Agonist/Serotonin Reuptake Inhibitor with Preclinical Antipsychotic-Like and Antidepressant-Like Activity
Journal of Pharmacology and Experimental Therapeutics·2009· 14 cited
The orphan GPCR, GPR88, modulates function of the striatal dopamine system: A possible therapeutic target for psychiatric disorders?
Molecular and Cellular Neuroscience·2009· 94 cited
Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia
Bioorganic & Medicinal Chemistry Letters·2009· 18 citedOpen Access
Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia
Journal of Pharmacology and Experimental Therapeutics·2009· 266 cited
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist
Neuropharmacology·2009· 145 cited
Procognitive and Neuroprotective Activity of a Novel α7 Nicotinic Acetylcholine Receptor Agonist for Treatment of Neurodegenerative and Cognitive Disorders
Journal of Pharmacology and Experimental Therapeutics·2009· 99 cited
WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics
Psychopharmacology·2008· 23 cited
Old and New Pharmacology: Positive Allosteric Modulation of the α7 Nicotinic Acetylcholine Receptor by the 5-Hydroxytryptamine2B/C Receptor Antagonist SB-206553 (3,5-Dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b′]di pyrrole-1(2 H)-carboxamide)
Journal of Pharmacology and Experimental Therapeutics·2008· 65 cited
PRE-CLINICAL CHARACTERIZATION OF THE ALPHA-7 NICOTINIC RECEPTOR AGONIST SEN12333/WAY-317538
Schizophrenia Research·2008
Correlating Efficacy in Rodent Cognition Models with in Vivo 5-Hydroxytryptamine1A Receptor Occupancy by a Novel Antagonist, (R)-N-(2-Methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane Carboxamide (WAY-101405)
Journal of Pharmacology and Experimental Therapeutics·2008· 35 cited
P.3.d.019 Vabicaserin: effects of a novel 5-HT2C agonist on medial prefrontal cortex neurotransmission, cognition and sensorimotor gating
European Neuropsychopharmacology·2007· 5 cited
WAY-163909 [(7 bR,10 aR)-1,2,3,4,8,9,10,10 a-Octahydro-7 bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Preclinical Antipsychotic-Like Activity
Journal of Pharmacology and Experimental Therapeutics·2006· 145 cited
Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague-Dawley rats
Psychopharmacology·1999· 30 cited
page 1 of 2Next →

Frequent Co-authors

Karen L. Marquis(11), Thomas A. Comery(10), Sharon Rosenzweig‐Lipson(8), Rachel L. Navarra(7), Radka Graf(7), Julie Brennan(7), Sheree F. Logue(6), Zoë A. Hughes(6), Cody Kelley(5), Nicholas J. Brandon(4), Claudine Pulicicchio(4), Stacey J. Sukoff Rizzo(4), Renza Roncarati(4), John Dunlop(4), Virginia Pulito(3), Gary Stack(3), Boyd L. Harrison(3), Brian J. Platt(3), Chad E. Beyer(3), Carla Scali(3)